Drug Approval | March 29, 2023
Zydus receives final approval from USFDA for Loperamide Hydrochloride Capsules
Loperamide Hydrochloride Capsules USP, 2 mg had annual sales of US $34.7 million in the United States
Loperamide Hydrochloride Capsules USP, 2 mg had annual sales of US $34.7 million in the United States
The award recognizes and supports promising female scientists working in mass spectrometry
Lubiprostone capsule is indicated to treat certain types of constipation (chronic idiopathic constipation and irritable bowel syndrome with constipation)
ZYIL1 is a novel oral small molecule NLRP3 inhibitor which has demonstrated CSF penetration in non-human primates
Man Industries (India) Limited has received a new export order of approximately Rs. 1,300 crores.
New Building at Rockford, Illinois site will significantly increase equipment and capacity for injectable biologics and other self-administered therapies
Open, scalable, end-to-end solution to improve diagnostic quality and efficiency
Chronic Kidney Disease is a growing epidemic with 850 million people affected worldwide.
New GMP facility for clinical and small-scale commercial pharmaceutical lipids
Clinical studies are expected to start in Q2 2023.
Subscribe To Our Newsletter & Stay Updated
